ArticleeLife2024
mitoBK
Abstract read
In one paragraph
Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Potassium channels in cancer: from hallmarks to therapeutic targeting.Journal of physiology and biochemistry · 2026Review
- Slick K+ channels contribute to cardiac remodeling, fibrosis, and dysfunction in postinfarction hearts.JCI insight · 2026Article
- Ionic regulation of cancer cell stiffness and metastatic colonization via the MRTFA-KCNMB1 axis.Developmental cell · 2026Article
- Potential therapeutic targeting of BKMolecular oncology · 2026Review
- Dibenzoylmethane, a novel β-diketone pore blocker of large-conductance calcium-activated potassium channel.bioRxiv : the preprint server for biology · 2026Article
- Nitrogen Isotope Effects in Urea Metabolism: From Biochemistry toInternational journal of molecular sciences · 2026Review
- Targeting ion channel dysregulation in tumors: emerging therapeutic opportunities.Trends in pharmacological sciences · 2026Review
- The progression of triple-negative breast cancer is linked to a gradual decrease of the BK channel in the plasma membrane and an increase in intracellular structures.Pflugers Archiv : European journal of physiology · 2026Article
- Ionic Regulation of Mechanosurveillance and Metastasis via the MRTFA/KCNMB1 Axis.bioRxiv : the preprint server for biology · 2026Article
- Inhibition of cancerous properties of triple-negative MDA-MB-436 cells by targeting the KJournal of physiology and biochemistry · 2025Article
- Mitochondrial Transport Proteins in Cardiovascular Diseases: Metabolic Gatekeepers, Pathogenic Mediators and Therapeutic Targets.International journal of molecular sciences · 2025Review
- A review of the pathogenesis of mitochondria in breast cancer and progress of targeting mitochondria for breast cancer treatment.Journal of translational medicine · 2025Review
- Redox Regulation of Mitochondrial Potassium Channels Activity.Antioxidants (Basel, Switzerland) · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Helmut BischofDepartment of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany.ORCID https://orcid.org/0000-0003-2380-600X
Selina MaierDepartment of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany.
Piotr KoprowskiLaboratory of Intracellular Ion Channels, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.
Bogusz KulawiakLaboratory of Intracellular Ion Channels, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.ORCID https://orcid.org/0000-0002-4420-9557
Sandra BurgstallerDepartment of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany.ORCID https://orcid.org/0000-0002-3926-7023
Joanna JasińskaLaboratory of Intracellular Ion Channels, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.
Kristian SerafimovInstitute of Pharmaceutical Sciences, Pharmaceutical (Bio-)Analysis, University of Tübingen, Tübingen, Germany.
Monika ZochowskaLaboratory of Intracellular Ion Channels, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.
Dominic GrossDepartment of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany.
Werner SchrothDr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
Lucas MattDepartment of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany.
David Arturo Juarez LopezMedical Clinic IV, University Hospital Tübingen, Tübingen, Germany.
Ying ZhangDepartment of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany.
Irina BonzheimInstitute of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany.ORCID https://orcid.org/0000-0002-7732-0788
Florian A BüttnerDr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
Falko FendInstitute of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany.
Matthias SchwabDr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
Andreas L BirkenfeldMedical Clinic IV, University Hospital Tübingen, Tübingen, Germany.ORCID https://orcid.org/0000-0003-1407-9023
Roland MalliCenter for Medical Research, CF Bioimaging, Medical University of Graz, Graz, Austria.ORCID https://orcid.org/0000-0001-6327-8729
Michael LämmerhoferInstitute of Pharmaceutical Sciences, Pharmaceutical (Bio-)Analysis, University of Tübingen, Tübingen, Germany.
Piotr BednarczykDepartment of Physics and Biophysics, Warsaw University of Life Sciences (SGGW), Warsaw, Poland.ORCID https://orcid.org/0000-0002-7125-0715
Adam SzewczykLaboratory of Intracellular Ion Channels, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.ORCID https://orcid.org/0000-0001-5519-260X
Robert LukowskiDepartment of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany.ORCID https://orcid.org/0000-0002-4564-3574
Funding
Austrian Science Fund I-3716Austrian Science Fund J-4457Deutsche Forschungsgemeinschaft 335549539Deutsche Forschungsgemeinschaft Germany's Excellence Strategy-EXC 2180-390900677Deutsche Forschungsgemeinschaft LU 1490/10-1Deutsche Forschungsgemeinschaft LU 1490/12-1Deutsche Forschungsgemeinschaft MA 8113/2-1Interfaculty Centre for Pharmacogenomics and Pharma Research Membrane associated Drug Targets in Personalized Cancer MedicineNarodowe Centrum Nauki 2019/34/A/NZ1/00352
Abstract
Alterations in the function of K
Indexed as
Breast NeoplasmsAnimalsCell Line, TumorCell ProliferationEnergy MetabolismFemaleHumansLarge-Conductance Calcium-Activated Potassium Channel alpha SubunitsMiceMitochondriaMitochondrial MembranesKCNMA1 protein, humanLarge-Conductance Calcium-Activated Potassium Channel alpha Subunitsbiosensorsbreast cancercancer biologycell biologyhumanK+ channelsKcnma1metabolic reprogrammingmitoBKCamouseSlo1Warburg effect
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.